{"transactions":[{"id":867106,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T21:18:31.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":65829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":65829,"derivative":{"exercise_price":13.78,"expiration_date":"2036-02-29","underlying":"Common Stock","underlying_shares":65829},"source":{"system":"sec-edgar","filing":"0001193125-26-088260","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526088260/ownership.xml","form_type":"4"}},{"id":867105,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-03T21:18:31.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1211,"price":13.78,"value":16687.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person."}],"balance_after":156794,"source":{"system":"sec-edgar","filing":"0001193125-26-088260","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526088260/ownership.xml","form_type":"4"}},{"id":867104,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-03T21:18:31.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":46080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit"}],"balance_after":158005,"source":{"system":"sec-edgar","filing":"0001193125-26-088260","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526088260/ownership.xml","form_type":"4"}},{"id":944473,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-01-07T21:05:11.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":10397,"price":9.21,"value":95756.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person."}],"balance_after":101528,"source":{"system":"sec-edgar","filing":"0001193125-26-006291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312526006291/ownership.xml","form_type":"4"}},{"id":1228394,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T21:21:45.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":57143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":57143,"derivative":{"exercise_price":10.09,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":57143},"source":{"system":"sec-edgar","filing":"0000950170-25-032086","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025032086/ownership.xml","form_type":"4"}},{"id":1228393,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-04T21:21:45.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":2572,"price":8.99,"value":23122.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":111925,"source":{"system":"sec-edgar","filing":"0000950170-25-032086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025032086/ownership.xml","form_type":"4"}},{"id":1228392,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-04T21:21:45.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit"}],"balance_after":114497,"source":{"system":"sec-edgar","filing":"0000950170-25-032086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025032086/ownership.xml","form_type":"4"}},{"id":1308016,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-01-07T22:22:20.000Z","date":"2025-01-03","kind":"sale","planned":false,"acquired":false,"shares":7074,"price":12.18,"value":86161.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":74497,"source":{"system":"sec-edgar","filing":"0000950170-25-003028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025003028/ownership.xml","form_type":"4"}},{"id":1596210,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T21:10:22.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":46752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":46752,"derivative":{"exercise_price":32.66,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":46752},"source":{"system":"sec-edgar","filing":"0000950170-24-025906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024025906/ownership.xml","form_type":"4"}},{"id":1596209,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-05T21:10:22.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":2297,"price":32.99,"value":75778.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":81571,"source":{"system":"sec-edgar","filing":"0000950170-24-025906","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024025906/ownership.xml","form_type":"4"}},{"id":1596208,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-05T21:10:22.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":32394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":83868,"source":{"system":"sec-edgar","filing":"0000950170-24-025906","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024025906/ownership.xml","form_type":"4"}},{"id":1685480,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-01-05T21:45:39.000Z","date":"2024-01-03","kind":"sale","planned":false,"acquired":false,"shares":3805,"price":29.46,"value":112095.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":51474,"source":{"system":"sec-edgar","filing":"0000950170-24-002504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024002504/ownership.xml","form_type":"4"}},{"id":1973473,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T22:10:35.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":34674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2023 with respect to shares of Common Stock, with 33% vesting on January 1, 2024 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":34674,"derivative":{"exercise_price":40.75,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":34674},"source":{"system":"sec-edgar","filing":"0001209191-23-015722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123015722/doc4.xml","form_type":"4"}},{"id":1973472,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-03T22:10:35.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":1088,"price":43.88,"value":47741.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on March 1, 2023."}],"balance_after":55279,"source":{"system":"sec-edgar","filing":"0001209191-23-015722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123015722/doc4.xml","form_type":"4"}},{"id":1973471,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-03T22:10:35.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":12269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":56367,"source":{"system":"sec-edgar","filing":"0001209191-23-015722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123015722/doc4.xml","form_type":"4"}},{"id":1973470,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-03T22:10:35.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":24539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":44098,"source":{"system":"sec-edgar","filing":"0001209191-23-015722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123015722/doc4.xml","form_type":"4"}},{"id":2060419,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-01-06T22:19:11.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":1138,"price":37.21,"value":42344.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023."}],"balance_after":19559,"source":{"system":"sec-edgar","filing":"0001209191-23-002410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123002410/doc4.xml","form_type":"4"}},{"id":2350340,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-05T02:09:44.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":14109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 incorrectly reported the number of options granted as 9,648."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 1, 2022 with respect to shares of Common Stock, with 33% vesting on January 1, 2023 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4 incorrectly reported the number of options granted as 9,648."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4 incorrectly reported the number of options granted as 9,648."}],"balance_after":14109,"derivative":{"exercise_price":79.85,"expiration_date":"2032-02-28","underlying":"Common Stock","underlying_shares":14109},"source":{"system":"sec-edgar","filing":"0001209191-22-016539","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122016539/doc4a.xml","form_type":"4/A","original_submission_date":"2022-03-03"}},{"id":2354416,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T00:34:32.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":9648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 1, 2022 with respect to shares of Common Stock, with 33% vesting on January 1, 2023 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":9648,"derivative":{"exercise_price":79.85,"expiration_date":"2032-02-28","underlying":"Common Stock","underlying_shares":9648},"source":{"system":"sec-edgar","filing":"0001209191-22-015909","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122015909/doc4.xml","form_type":"4"}},{"id":2354415,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-04T00:34:32.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":9648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":20697,"source":{"system":"sec-edgar","filing":"0001209191-22-015909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122015909/doc4.xml","form_type":"4"}},{"id":2354414,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-04T00:34:32.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":11049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":11049,"source":{"system":"sec-edgar","filing":"0001209191-22-015909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122015909/doc4.xml","form_type":"4"}},{"id":2641237,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T20:44:01.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 1, 2021 with respect to 130,000 shares of Common Stock, with 25% vesting on July 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":130000,"derivative":{"exercise_price":171.65,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-21-045513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121045513/doc4.xml","form_type":"4"}},{"id":2892061,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2021-01-28T22:31:46.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":125000,"derivative":{"exercise_price":32.8,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-005915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919121005915/doc4.xml","form_type":"4"}},{"id":3204974,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2020-03-18T00:19:01.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":8.41,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-019830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120019830/doc4.xml","form_type":"4"}},{"id":3380141,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":63306,"kind":"person","name":"BASTA JAMES","position":1,"cik":"0001792726","reported_name":"BASTA JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2019-11-05T22:23:55.000Z","date":"2019-11-04","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter."}],"balance_after":175000,"derivative":{"exercise_price":15.36,"expiration_date":"2029-11-03","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-19-055289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919119055289/doc4.xml","form_type":"4"}}]}